DANIEL MEDINA to Drug Resistance, Neoplasm
This is a "connection" page, showing publications DANIEL MEDINA has written about Drug Resistance, Neoplasm.
Connection Strength
0.112
-
Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs. Cancer Lett. 2014 Aug 01; 350(1-2):52-60.
Score: 0.077
-
The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma. Oncotarget. 2016 May 17; 7(20):29689-707.
Score: 0.022
-
Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis. Cancer Res. 2007 Dec 15; 67(24):12026-33.
Score: 0.012